Sprague–Dawley rats with severe inflammatory bowel disease were administered r-irisin (18 ng/mL b.w.; twice a week) for 3 weeks had reduced dextran sodium sulfate (DSS)-stimulated colon inflammation and increased bone formation (Table 5) [83]. Here, FNDC5 is linked to inflammatory bowel disease.